LUCYW · Innovative Eyewear Inc

The reporting person is aware that the transaction reported herein resulted in a short-swing profit under Section 16(b) of the Securities Exchange Act of 1934 and agreed to voluntarily disgorged $1,036.20, the full amount of such profit to the issuer, which amount was paid in full on January 21, 2026.

The reporting person is aware that the transaction reported herein resulted in a short-swing profit under Section 16(b) of the Securities Exchange Act of 1934 and agreed to voluntarily disgorged $489.00, the full amount of such profit to the issuer, which amount was paid in full on January 15, 2026.

The reporting person is aware that the transaction reported herein resulted in a short-swing profit under Section 16(b) of the Securities Exchange Act of 1934 and agreed to voluntarily disgorged $489.00, the full amount of such profit to the issuer, which amount was paid in full on January 15, 2026.

The reporting person is aware that the transaction reported herein resulted in a short-swing profit under Section 16(b) of the Securities Exchange Act of 1934 and agreed to voluntarily disgorged $629.45, the full amount of such profit to the issuer, which amount was paid in full on January 11, 2026.

The reporting person is aware that the transaction reported herein resulted in a short-swing profit under Section 16(b) of the Securities Exchange Act of 1934 and agreed to voluntarily disgorged $551.35, the full amount of such profit to the issuer, which amount was paid in full on January 12, 2026.

The prices reported are volume weighted-average prices and include commissions paid in per share prices. These shares of Common Stock were purchased or sold in multiple transactions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the SEC staff, upon request, all information regarding the number of shares purchased or sold at each price.

The shares of Common Stock are held jointly by Vladimir Galkin and Angelica Galkin, husband and wife.

The prices reported are volume weighted-average prices and include commissions paid in per share prices. These shares of Common Stock were purchased or sold in multiple transactions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the SEC staff, upon request, all information regarding the number of shares purchased or sold at each price.

The shares of Common Stock are held jointly by Vladimir Galkin and Angelica Galkin, husband and wife.

The prices reported include commissions paid in per share prices.

The shares of Common Stock are held jointly by Vladimir Galkin and Angelica Galkin, husband and wife.

The prices reported include commissions paid in per share prices.

The shares of Common Stock are held jointly by Vladimir Galkin and Angelica Galkin, husband and wife.

The prices reported include commissions paid in per share prices.

The shares of Common Stock are held jointly by Vladimir Galkin and Angelica Galkin, husband and wife.

The prices reported include commissions paid in per share prices.

The shares of Common Stock are held jointly by Vladimir Galkin and Angelica Galkin, husband and wife.

The prices reported include commissions paid in per share prices.

The shares of Common Stock are held jointly by Vladimir Galkin and Angelica Galkin, husband and wife.

The prices reported include commissions paid in per share prices.

The shares of Common Stock are held jointly by Vladimir Galkin and Angelica Galkin, husband and wife.

The prices reported include commissions paid in per share prices.

The shares of Common Stock are held jointly by Vladimir Galkin and Angelica Galkin, husband and wife.

The prices reported include commissions paid in per share prices.

The shares of Common Stock are held jointly by Vladimir Galkin and Angelica Galkin, husband and wife.

The prices reported include commissions paid in per share prices.

The shares of Common Stock are held jointly by Vladimir Galkin and Angelica Galkin, husband and wife.

The prices reported include commissions paid in per share prices.

The shares of Common Stock are held jointly by Vladimir Galkin and Angelica Galkin, husband and wife.

The prices reported include commissions paid in per share prices.

The shares of Common Stock are held jointly by Vladimir Galkin and Angelica Galkin, husband and wife.

The shares of Common Stock are held jointly by Vladimir Galkin and Angelica Galkin, husband and wife.

The shares of Common Stock are held jointly by Vladimir Galkin and Angelica Galkin, husband and wife.

The shares of Common Stock are held jointly by Vladimir Galkin and Angelica Galkin, husband and wife.

The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (7) in this Form 4.

The purchases were executed in multiple trades at prices ranging from $8.76 to $8.88.

The shares of Common Stock are held jointly by Vladimir Galkin and Angelica Galkin, husband and wife.

The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (7) in this Form 4.

The purchases were executed in multiple trades at prices ranging from $9.52 to $9.66.

The shares of Common Stock are held jointly by Vladimir Galkin and Angelica Galkin, husband and wife.

The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (7) in this Form 4.

The purchasess were executed in multiple trades at prices ranging from $9.47 to $9.50.

The shares of Common Stock are held jointly by Vladimir Galkin and Angelica Galkin, husband and wife.

The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (7) in this Form 4.

The purchases were executed in multiple trades at prices ranging from $8.71 to $8.75.

The shares of Common Stock are held jointly by Vladimir Galkin and Angelica Galkin, husband and wife.

The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (7) in this Form 4.

The purchase were executed in multiple trades at prices ranging from $8.53 to $8.70.

The shares of Common Stock are held jointly by Vladimir Galkin and Angelica Galkin, husband and wife.

The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (6) in this Form 4.

The purchases were executed in multiple trades at prices ranging from $10.11 to $10.20.

The shares of Common Stock are held jointly by Vladimir Galkin and Angelica Galkin, husband and wife. Accordingly, this Form 4 is being filed jointly by: (i) each of Vladimir Galkin and Angelica Galkin, husband and wife; and (ii) The Angelica Galkin Revocable Trust, dated April 21, 2018 ('Galkin Revocable Trust'). On September 20, 2024, the Galkin Revocable Trust ceased to be a beneficial owner of Common Stock upon the transfer of 799,208 shares of Common Stock of Issuer (representing all of its shares of Common Stock) to a joint account held by Vladimir Galkin and Angelica Galkin.

The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (6) in this Form 4.

The sales were executed in multiple trades at a price of $10.79.

The shares of Common Stock are held jointly by Vladimir Galkin and Angelica Galkin, husband and wife. Accordingly, this Form 4 is being filed jointly by: (i) each of Vladimir Galkin and Angelica Galkin, husband and wife; and (ii) The Angelica Galkin Revocable Trust, dated April 21, 2018 ('Galkin Revocable Trust'). On September 20, 2024, the Galkin Revocable Trust ceased to be a beneficial owner of Common Stock upon the transfer of 799,208 shares of Common Stock of Issuer (representing all of its shares of Common Stock) to a joint account held by Vladimir Galkin and Angelica Galkin.

The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (6) in this Form 4.

The purchases were executed in multiple trades at prices ranging from $10.33 to $10.37.

The shares of Common Stock are held jointly by Vladimir Galkin and Angelica Galkin, husband and wife. Accordingly, this Form 4 is being filed jointly by: (i) each of Vladimir Galkin and Angelica Galkin, husband and wife; and (ii) The Angelica Galkin Revocable Trust, dated April 21, 2018 ('Galkin Revocable Trust'). On September 20, 2024, the Galkin Revocable Trust ceased to be a beneficial owner of Common Stock upon the transfer of 799,208 shares of Common Stock of Issuer (representing all of its shares of Common Stock) to a joint account held by Vladimir Galkin and Angelica Galkin.

The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (6) in this Form 4.

The purchases were executed in multiple trades at prices ranging from $10.11 to $10.20.

The shares of Common Stock are held jointly by Vladimir Galkin and Angelica Galkin, husband and wife. Accordingly, this Form 4 is being filed jointly by: (i) each of Vladimir Galkin and Angelica Galkin, husband and wife; and (ii) The Angelica Galkin Revocable Trust, dated April 21, 2018 ('Galkin Revocable Trust'). On September 20, 2024, the Galkin Revocable Trust ceased to be a beneficial owner of Common Stock upon the transfer of 799,208 shares of Common Stock of Issuer (representing all of its shares of Common Stock) to a joint account held by Vladimir Galkin and Angelica Galkin.

The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (6) in this Form 4.

The purchases were executed in multiple trades at prices ranging from $10.33 to $10.37.

The shares of Common Stock are held jointly by Vladimir Galkin and Angelica Galkin, husband and wife. Accordingly, this Form 4 is being filed jointly by: (i) each of Vladimir Galkin and Angelica Galkin, husband and wife; and (ii) The Angelica Galkin Revocable Trust, dated April 21, 2018 ('Galkin Revocable Trust'). On September 20, 2024, the Galkin Revocable Trust ceased to be a beneficial owner of Common Stock upon the transfer of 799,208 shares of Common Stock of Issuer (representing all of its shares of Common Stock) to a joint account held by Vladimir Galkin and Angelica Galkin.

The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (6) in this Form 4.

The sales were executed in multiple trades at a price of $10.00.

The shares of Common Stock are held jointly by Vladimir Galkin and Angelica Galkin, husband and wife. Accordingly, this Form 4 is being filed jointly by: (i) each of Vladimir Galkin and Angelica Galkin, husband and wife; and (ii) The Angelica Galkin Revocable Trust, dated April 21, 2018 ('Galkin Revocable Trust'). On September 20, 2024, the Galkin Revocable Trust ceased to be a beneficial owner of Common Stock upon the transfer of 799,208 shares of Common Stock of Issuer (representing all of its shares of Common Stock) to a joint account held by Vladimir Galkin and Angelica Galkin.

The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (6) in this Form 4.

The sales were executed in multiple trades at a price of $10.00.

The shares of Common Stock are held jointly by Vladimir Galkin and Angelica Galkin, husband and wife. Accordingly, this Form 4 is being filed jointly by: (i) each of Vladimir Galkin and Angelica Galkin, husband and wife; and (ii) The Angelica Galkin Revocable Trust, dated April 21, 2018 ('Galkin Revocable Trust'). On September 20, 2024, the Galkin Revocable Trust ceased to be a beneficial owner of Common Stock upon the transfer of 799,208 shares of Common Stock of Issuer (representing all of its shares of Common Stock) to a joint account held by Vladimir Galkin and Angelica Galkin.

The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (6) in this Form 4.

The sales were executed in multiple trades at a price of $10.79.

The shares of Common Stock are held jointly by Vladimir Galkin and Angelica Galkin, husband and wife. Accordingly, this Form 4 is being filed jointly by: (i) each of Vladimir Galkin and Angelica Galkin, husband and wife; and (ii) The Angelica Galkin Revocable Trust, dated April 21, 2018 ('Galkin Revocable Trust'). On September 20, 2024, the Galkin Revocable Trust ceased to be a beneficial owner of Common Stock upon the transfer of 799,208 shares of Common Stock of Issuer (representing all of its shares of Common Stock) to a joint account held by Vladimir Galkin and Angelica Galkin.

The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (10) in this Form 4.

The purchases were executed in multiple trades at prices ranging from $8.10 to $8.27.

The Angelica Galkin Revocable Trust, dated April 21, 2018 ("Galkin Revocable Trust") directly holds the shares of Common Stock. Angelica Galkin is the sole trustee and beneficiary of the Galkin Revocable Trust. Angelica Galkin has delegated to Vladimir Galkin the shared right to direct the voting and disposition of the securities owned by the Galkin Revocable Trust. Accordingly, each of Vladimir Galkin and Angelica Galkin may be deemed to beneficially own the securities owned directly by Galkin Revocable Trust. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16") or for any other purpose.

The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (10) in this Form 4.

The sales were executed in multiple trades at a price of $9.79.

The Angelica Galkin Revocable Trust, dated April 21, 2018 ("Galkin Revocable Trust") directly holds the shares of Common Stock. Angelica Galkin is the sole trustee and beneficiary of the Galkin Revocable Trust. Angelica Galkin has delegated to Vladimir Galkin the shared right to direct the voting and disposition of the securities owned by the Galkin Revocable Trust. Accordingly, each of Vladimir Galkin and Angelica Galkin may be deemed to beneficially own the securities owned directly by Galkin Revocable Trust. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16") or for any other purpose.

The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (10) in this Form 4.

The purchases were executed in multiple trades at prices ranging from $9.01 to $9.20.

The Angelica Galkin Revocable Trust, dated April 21, 2018 ("Galkin Revocable Trust") directly holds the shares of Common Stock. Angelica Galkin is the sole trustee and beneficiary of the Galkin Revocable Trust. Angelica Galkin has delegated to Vladimir Galkin the shared right to direct the voting and disposition of the securities owned by the Galkin Revocable Trust. Accordingly, each of Vladimir Galkin and Angelica Galkin may be deemed to beneficially own the securities owned directly by Galkin Revocable Trust. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16") or for any other purpose.

The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (10) in this Form 4.

The sales were executed in multiple trades at a price of $8.50.

The Angelica Galkin Revocable Trust, dated April 21, 2018 ("Galkin Revocable Trust") directly holds the shares of Common Stock. Angelica Galkin is the sole trustee and beneficiary of the Galkin Revocable Trust. Angelica Galkin has delegated to Vladimir Galkin the shared right to direct the voting and disposition of the securities owned by the Galkin Revocable Trust. Accordingly, each of Vladimir Galkin and Angelica Galkin may be deemed to beneficially own the securities owned directly by Galkin Revocable Trust. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16") or for any other purpose.

The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (10) in this Form 4.

The sales were executed in multiple trades at a price of $8.79.

The Angelica Galkin Revocable Trust, dated April 21, 2018 ("Galkin Revocable Trust") directly holds the shares of Common Stock. Angelica Galkin is the sole trustee and beneficiary of the Galkin Revocable Trust. Angelica Galkin has delegated to Vladimir Galkin the shared right to direct the voting and disposition of the securities owned by the Galkin Revocable Trust. Accordingly, each of Vladimir Galkin and Angelica Galkin may be deemed to beneficially own the securities owned directly by Galkin Revocable Trust. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16") or for any other purpose.

The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (10) in this Form 4.

The sales were executed in multiple trades at a price of $9.50.

The Angelica Galkin Revocable Trust, dated April 21, 2018 ("Galkin Revocable Trust") directly holds the shares of Common Stock. Angelica Galkin is the sole trustee and beneficiary of the Galkin Revocable Trust. Angelica Galkin has delegated to Vladimir Galkin the shared right to direct the voting and disposition of the securities owned by the Galkin Revocable Trust. Accordingly, each of Vladimir Galkin and Angelica Galkin may be deemed to beneficially own the securities owned directly by Galkin Revocable Trust. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16") or for any other purpose.

The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (10) in this Form 4.

The purchases were executed in multiple trades at prices ranging from $8.76 to $9.00.

The Angelica Galkin Revocable Trust, dated April 21, 2018 ("Galkin Revocable Trust") directly holds the shares of Common Stock. Angelica Galkin is the sole trustee and beneficiary of the Galkin Revocable Trust. Angelica Galkin has delegated to Vladimir Galkin the shared right to direct the voting and disposition of the securities owned by the Galkin Revocable Trust. Accordingly, each of Vladimir Galkin and Angelica Galkin may be deemed to beneficially own the securities owned directly by Galkin Revocable Trust. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16") or for any other purpose.

The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (10) in this Form 4.

The purchases were executed in multiple trades at prices ranging from $8.51 to $8.75.

The Angelica Galkin Revocable Trust, dated April 21, 2018 ("Galkin Revocable Trust") directly holds the shares of Common Stock. Angelica Galkin is the sole trustee and beneficiary of the Galkin Revocable Trust. Angelica Galkin has delegated to Vladimir Galkin the shared right to direct the voting and disposition of the securities owned by the Galkin Revocable Trust. Accordingly, each of Vladimir Galkin and Angelica Galkin may be deemed to beneficially own the securities owned directly by Galkin Revocable Trust. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16") or for any other purpose.

The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (8) in this Form 4.

The purchases were executed in multiple trades at prices ranging from $7.53 to $7.74.

The Angelica Galkin Revocable Trust, dated April 21, 2018 ("Galkin Revocable Trust") directly holds the shares of Common Stock. Angelica Galkin is the sole trustee and beneficiary of the Galkin Revocable Trust. Angelica Galkin has delegated to Vladimir Galkin the shared right to direct the voting and disposition of the securities owned by the Galkin Revocable Trust. Accordingly, each of Vladimir Galkin and Angelica Galkin may be deemed to beneficially own the securities owned directly by Galkin Revocable Trust. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16") or for any other purpose.

The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (8) in this Form 4.

The purchases were executed in multiple trades at prices ranging from $7.76 to $8.00.

The Angelica Galkin Revocable Trust, dated April 21, 2018 ("Galkin Revocable Trust") directly holds the shares of Common Stock. Angelica Galkin is the sole trustee and beneficiary of the Galkin Revocable Trust. Angelica Galkin has delegated to Vladimir Galkin the shared right to direct the voting and disposition of the securities owned by the Galkin Revocable Trust. Accordingly, each of Vladimir Galkin and Angelica Galkin may be deemed to beneficially own the securities owned directly by Galkin Revocable Trust. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16") or for any other purpose.

The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (8) in this Form 4.

The sales were executed in multiple trades at a price of $8.20.

The Angelica Galkin Revocable Trust, dated April 21, 2018 ("Galkin Revocable Trust") directly holds the shares of Common Stock. Angelica Galkin is the sole trustee and beneficiary of the Galkin Revocable Trust. Angelica Galkin has delegated to Vladimir Galkin the shared right to direct the voting and disposition of the securities owned by the Galkin Revocable Trust. Accordingly, each of Vladimir Galkin and Angelica Galkin may be deemed to beneficially own the securities owned directly by Galkin Revocable Trust. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16") or for any other purpose.

The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (8) in this Form 4.

The purchases were executed in multiple trades at a price of $8.10.

The Angelica Galkin Revocable Trust, dated April 21, 2018 ("Galkin Revocable Trust") directly holds the shares of Common Stock. Angelica Galkin is the sole trustee and beneficiary of the Galkin Revocable Trust. Angelica Galkin has delegated to Vladimir Galkin the shared right to direct the voting and disposition of the securities owned by the Galkin Revocable Trust. Accordingly, each of Vladimir Galkin and Angelica Galkin may be deemed to beneficially own the securities owned directly by Galkin Revocable Trust. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16") or for any other purpose.

The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (8) in this Form 4.

The purchases were executed in multiple trades at prices ranging from $7.41 to $7.47.

The Angelica Galkin Revocable Trust, dated April 21, 2018 ("Galkin Revocable Trust") directly holds the shares of Common Stock. Angelica Galkin is the sole trustee and beneficiary of the Galkin Revocable Trust. Angelica Galkin has delegated to Vladimir Galkin the shared right to direct the voting and disposition of the securities owned by the Galkin Revocable Trust. Accordingly, each of Vladimir Galkin and Angelica Galkin may be deemed to beneficially own the securities owned directly by Galkin Revocable Trust. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16") or for any other purpose.

The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (8) in this Form 4.

The sales were executed in multiple trades at a price of $8.12.

The Angelica Galkin Revocable Trust, dated April 21, 2018 ("Galkin Revocable Trust") directly holds the shares of Common Stock. Angelica Galkin is the sole trustee and beneficiary of the Galkin Revocable Trust. Angelica Galkin has delegated to Vladimir Galkin the shared right to direct the voting and disposition of the securities owned by the Galkin Revocable Trust. Accordingly, each of Vladimir Galkin and Angelica Galkin may be deemed to beneficially own the securities owned directly by Galkin Revocable Trust. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16") or for any other purpose.

The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (12) in this Form 4.

The purchases were executed in multiple trades at prices ranging from $7.55 to $7.74.

The Angelica Galkin Revocable Trust, dated April 21, 2018 ("Galkin Revocable Trust") directly holds the shares of Common Stock. Angelica Galkin is the sole trustee and beneficiary of the Galkin Revocable Trust. Angelica Galkin has delegated to Vladimir Galkin the shared right to direct the voting and disposition of the securities owned by the Galkin Revocable Trust. Accordingly, each of Vladimir Galkin and Angelica Galkin may be deemed to beneficially own the securities owned directly by Galkin Revocable Trust. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16") or for any other purpose.

The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (12) in this Form 4.

The purchases were executed in multiple trades at prices ranging from $6.77 to $6.88.

The Angelica Galkin Revocable Trust, dated April 21, 2018 ("Galkin Revocable Trust") directly holds the shares of Common Stock. Angelica Galkin is the sole trustee and beneficiary of the Galkin Revocable Trust. Angelica Galkin has delegated to Vladimir Galkin the shared right to direct the voting and disposition of the securities owned by the Galkin Revocable Trust. Accordingly, each of Vladimir Galkin and Angelica Galkin may be deemed to beneficially own the securities owned directly by Galkin Revocable Trust. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16") or for any other purpose.